US6861571B1
(en)
*
|
1994-11-28 |
2005-03-01 |
The Procter & Gamble Company |
Article having a lotioned topsheet
|
AU4467396A
(en)
*
|
1994-12-12 |
1996-07-10 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain, inflammation and spasm
|
US6413961B1
(en)
|
1995-12-12 |
2002-07-02 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain and inflammation
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US6929801B2
(en)
*
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
US6916486B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of analgesics
|
US6923983B2
(en)
*
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
US6916487B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiemetics
|
US6512010B1
(en)
*
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
GR1002847B
(el)
|
1997-05-06 |
1998-01-27 |
|
Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
|
US6767902B2
(en)
*
|
1997-09-17 |
2004-07-27 |
The Population Council, Inc. |
Androgen as a male contraceptive and non-contraceptive androgen replacement
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US20030185761A1
(en)
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
EP1029536B1
(de)
*
|
1997-10-01 |
2007-11-28 |
Novadel Pharma Inc. |
Nichtpolare Spray zur bukkalen Verabreichung
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US5968919A
(en)
*
|
1997-10-16 |
1999-10-19 |
Macrochem Corporation |
Hormone replacement therapy drug formulations for topical application to the skin
|
US7098206B2
(en)
|
1998-01-21 |
2006-08-29 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
US6998400B2
(en)
|
1998-01-22 |
2006-02-14 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
EP1051163A2
(de)
*
|
1998-01-29 |
2000-11-15 |
Sepracor, Inc. |
Methoden und zusammenstellungen zur hilfe beim einstellen des rauchens und zur behandlung von schmerzen und anderen krankheiten durch verwendung von optisch reinem (-)-bupropion
|
WO1999038504A1
(en)
|
1998-01-29 |
1999-08-05 |
Sepracor Inc. |
Pharmaceutical uses of optically pure (-)-bupropion
|
AU2349999A
(en)
*
|
1998-01-29 |
1999-08-16 |
Sepracor, Inc. |
Pharmacological uses of pure (+) -bupropion
|
DE19814084B4
(de)
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
IL124764A0
(en)
*
|
1998-06-04 |
1999-01-26 |
Univ Ben Gurion |
Topical composition for treatment of baldness
|
DE19825591A1
(de)
*
|
1998-06-09 |
1999-12-23 |
Jenapharm Gmbh |
Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
|
GR1003199B
(el)
|
1998-08-14 |
1999-09-01 |
|
Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες
|
NZ509618A
(en)
|
1998-08-20 |
2003-09-26 |
3M Innovative Properties Co |
A patch-in-a-bottle that provides a fluid composition, which is applied to a surface and subsequently dries to form a covering, such as a patch
|
WO2000033827A1
(en)
*
|
1998-12-08 |
2000-06-15 |
Planisphere Corp. |
Bupropion to treat viral diseases
|
GB9828480D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Dermatech Limited |
Transdermal drug delivery system
|
DE60036915T2
(de)
|
1999-01-13 |
2008-08-07 |
Alchemia Oncology Pty Ltd., Hawthorn |
Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
|
US6734213B2
(en)
|
1999-01-20 |
2004-05-11 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
US6855820B2
(en)
|
1999-01-20 |
2005-02-15 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
KR100390870B1
(ko)
*
|
1999-02-09 |
2003-07-10 |
주식회사 삼양사 |
경피투여용 항구토제 조성물 및 이를 포함하는 제제
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
US6342496B1
(en)
|
1999-03-01 |
2002-01-29 |
Sepracor Inc. |
Bupropion metabolites and methods of use
|
PL350917A1
(en)
|
1999-03-05 |
2003-02-10 |
Procter & Gamble |
C16 unsaturated fp-selective prostaglandins analogs
|
DE19918105C1
(de)
*
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
|
US7258850B2
(en)
|
1999-05-04 |
2007-08-21 |
Aradigm Corporation |
Methods and compositions for treating erectile dysfunction
|
EP1175204A4
(de)
*
|
1999-05-04 |
2006-05-31 |
Aradigm Corp |
Aerosolformulierung und artikel zur steigerung der libido bei frauen durch momentane testosteronverabreichung
|
US6428769B1
(en)
*
|
1999-05-04 |
2002-08-06 |
Aradigm Corporation |
Acute testosterone administration
|
US6632419B2
(en)
|
1999-05-04 |
2003-10-14 |
Aradigm Corporation |
Increasing libido in humans via acute testosterone administration
|
US6280763B1
(en)
|
1999-05-10 |
2001-08-28 |
Pierce Management, Llc |
Apparatus and method for transdermal delivery of bupropion
|
US6312716B1
(en)
*
|
1999-05-10 |
2001-11-06 |
Peierce Management Llc |
Patch and method for transdermal delivery of bupropion base
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
US6595947B1
(en)
*
|
2000-05-22 |
2003-07-22 |
Becton, Dickinson And Company |
Topical delivery of vaccines
|
US20050008602A1
(en)
*
|
2000-06-05 |
2005-01-13 |
Sumitomo Electric Industries, Ltd. |
Oligopeptides for promoting hair growth
|
US7241731B2
(en)
|
2000-06-05 |
2007-07-10 |
Sumitomo Electric Industries, Ltd. |
Oligopeptides for promoting hair growth
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
US9066919B2
(en)
*
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
AUPQ879500A0
(en)
*
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
WO2002011768A1
(en)
|
2000-08-03 |
2002-02-14 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
DE10043321B4
(de)
*
|
2000-08-24 |
2005-07-28 |
Neurobiotec Gmbh |
Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
DE10041479A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
|
DE10053397A1
(de)
*
|
2000-10-20 |
2002-05-02 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
DE10042411A1
(de)
*
|
2000-08-30 |
2002-03-28 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Abgabe von Exemestan
|
ATE460939T1
(de)
*
|
2000-08-30 |
2010-04-15 |
Unimed Pharmaceuticals Llc |
Verfahren zur behandlung von erektionsstörungen und steigerung der libido bei männern
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
WO2002020020A1
(en)
*
|
2000-09-08 |
2002-03-14 |
Pharmacia Italia S.P.A. |
Exemestane as chemopreventing agent
|
DE10064453A1
(de)
*
|
2000-12-16 |
2002-07-04 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
US20020177626A1
(en)
*
|
2001-01-19 |
2002-11-28 |
Cook Graham D. |
Treatment of sleep disturbances
|
FR2815256A1
(fr)
*
|
2001-01-23 |
2002-04-19 |
Oreal |
Composition, notamment cosmetique, comprenant au moins un derive de sapogenine et au moins un solubilisant du derive de sapogenine
|
JP3767392B2
(ja)
*
|
2001-02-05 |
2006-04-19 |
日産自動車株式会社 |
エンジンのカム軸回転位相検出装置及びシリンダ吸入空気量算出装置
|
US20020172732A1
(en)
*
|
2001-03-21 |
2002-11-21 |
Wies Ter Laak |
Composition comprising cocoa
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
JP2005503425A
(ja)
*
|
2001-05-24 |
2005-02-03 |
アレックザ モレキュラー デリヴァリー コーポレイション |
所定の吸入ルートによる薬剤エステルの送出
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7244703B2
(en)
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
EP1408896B1
(de)
*
|
2001-06-22 |
2016-01-20 |
CPEX Pharmaceuticals, Inc. |
Pharmazeutische zusammensetzung
|
WO2003018023A1
(en)
*
|
2001-08-23 |
2003-03-06 |
Bruce Frome |
Compositions and methods for targeting cerebral circulation and treatment of headache
|
US20040138239A1
(en)
*
|
2001-08-23 |
2004-07-15 |
Bruce Frome |
Compositions and methods for targeting cerebral circulation and treatment of headache
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
US20050042303A1
(en)
*
|
2001-08-27 |
2005-02-24 |
Brown Tracey Jean |
Therapeutic protocols
|
US6723077B2
(en)
|
2001-09-28 |
2004-04-20 |
Hewlett-Packard Development Company, L.P. |
Cutaneous administration system
|
US20040120964A1
(en)
*
|
2001-10-29 |
2004-06-24 |
Mikszta John A. |
Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
|
JP2005511248A
(ja)
*
|
2001-10-29 |
2005-04-28 |
ベクトン・ディキンソン・アンド・カンパニー |
物質を送達するための方法およびデバイス
|
US20060173709A1
(en)
*
|
2005-01-31 |
2006-08-03 |
Traynor Daniel H |
Bodywash additive business methods
|
US7037513B1
(en)
|
2005-01-31 |
2006-05-02 |
Aquea Scientific Corporation |
Bodywash additives
|
US6998113B1
(en)
|
2005-01-31 |
2006-02-14 |
Aquea Scientific Corporation |
Bodywashes containing additives
|
US7025952B1
(en)
|
2005-01-31 |
2006-04-11 |
Aquea Scientific Corporation |
Methods of preparation and use of bodywashes containing additives
|
MXPA04006017A
(es)
|
2001-12-20 |
2005-06-08 |
Femmepharma Inc |
Suministro de farmacos por via vaginal.
|
US20040097871A1
(en)
*
|
2002-01-03 |
2004-05-20 |
Israel Yerushalmy |
Apparatus for treating sleep disorders
|
US20030143165A1
(en)
*
|
2002-01-25 |
2003-07-31 |
Allan Evans |
NSAID-containing topical formulations that demonstrate chemopreventive activity
|
US20030161802A1
(en)
*
|
2002-02-05 |
2003-08-28 |
Flammer Linda J. |
Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds
|
AUPS317302A0
(en)
*
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Metastable pharmaceutical compositions
|
AUPS317102A0
(en)
*
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
AU2003238543B2
(en)
*
|
2002-06-25 |
2008-02-28 |
Acrux Dds Pty Ltd |
Transdermal aerosol compositions
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
NZ537360A
(en)
*
|
2002-06-25 |
2006-09-29 |
Acrux Dds Pty Ltd |
Transdermal delivery rate control using amorphous pharmaceutical compositions
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
JP2005535614A
(ja)
*
|
2002-06-25 |
2005-11-24 |
コズメシューティック ソリューションズ プロプライエタリー リミテッド |
局所用美容組成物
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
DE10234673B4
(de)
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
EP1386605A1
(de)
*
|
2002-07-30 |
2004-02-04 |
Schwarz Pharma Ag |
Verbessertes transdermales System für die Verabreichung von Rotigotin
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
MXPA05004278A
(es)
|
2002-10-25 |
2005-10-05 |
Foamix Ltd |
Espuma cosmetica y farmaceutica.
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US20040086579A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Higgins James W. |
Dietary supplement comprising parthenolide
|
US7192614B2
(en)
|
2002-11-05 |
2007-03-20 |
Gelstat Corporation |
Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US7374772B2
(en)
*
|
2002-11-07 |
2008-05-20 |
Bommarito Alexander A |
Topical antifungal treatment
|
JP2006514633A
(ja)
*
|
2002-11-26 |
2006-05-11 |
アレックザ ファーマシューティカルズ, インコーポレイテッド |
吸入によって送達される抗精神病薬を用いた頭痛の治療
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
AU2003294470B2
(en)
|
2002-11-26 |
2009-09-17 |
Alexza Pharmaceuticals, Inc. |
Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
DE60204229T2
(de)
*
|
2002-12-02 |
2006-02-02 |
Schwarz Pharma Ag |
Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
|
US20040220198A1
(en)
*
|
2002-12-20 |
2004-11-04 |
Kasturi Haldar |
Methods for treating malaria by modulation of G protein function
|
JP2006515026A
(ja)
*
|
2003-01-02 |
2006-05-18 |
フェムファーマ ホールディング カンパニー, インコーポレイテッド |
乳房の疾患および障害の処置のための薬学的調製物
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
US20040247707A1
(en)
*
|
2003-01-06 |
2004-12-09 |
Le Roy Charles Richard |
Pearl blue fast acting, long lasting topical pain relief cream
|
ATE463246T1
(de)
*
|
2003-01-23 |
2010-04-15 |
Shire Holdings Ag |
Formulierung und verfahren zur behandlung von thrombocythämie
|
EP1444976A1
(de)
*
|
2003-02-10 |
2004-08-11 |
Novadel Pharma Inc. |
Bukkale, polare und nichtpolare Spray und Kapsel
|
ITFI20030070A1
(it)
*
|
2003-03-18 |
2004-09-19 |
Berlin Chemie Ag |
Formulazioni topiche stabilizzate contenenti ketoprofene
|
ES2535045T3
(es)
|
2003-04-10 |
2015-05-04 |
Vanderbilt Royalty Sub L.P. |
Usos y composiciones para administración de capsaicina
|
US7632531B2
(en)
*
|
2003-04-11 |
2009-12-15 |
International Flavors & Fragnances Inc. |
Alkyldienamides exhibiting taste and sensory effect in flavor compositions
|
US7361376B2
(en)
*
|
2003-04-11 |
2008-04-22 |
International Flavors & Fragrances Inc. |
Alkyldienamides exhibiting taste and sensory effect in flavor compositions
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
WO2004104490A1
(en)
|
2003-05-21 |
2004-12-02 |
Alexza Pharmaceuticals, Inc. |
Self-contained heating unit and drug-supply unit employing same
|
US20040247706A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal dietary supplement comprising parthenolide
|
US20040247705A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US20040259852A1
(en)
*
|
2003-06-18 |
2004-12-23 |
White Hillary D. |
Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
|
US8883769B2
(en)
*
|
2003-06-18 |
2014-11-11 |
White Mountain Pharma, Inc. |
Methods for the treatment of fibromyalgia and chronic fatigue syndrome
|
EP1488787A1
(de)
*
|
2003-06-20 |
2004-12-22 |
Berlin-Chemie Ag |
Topisch anzuwendende stabilisierte Arzneimittel enthaltend Ketoprofen
|
CA2433101A1
(en)
*
|
2003-06-23 |
2004-12-23 |
Igor Gonda |
Method of treatment of a female suffering from androgen insufficiency
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
US6884906B2
(en)
*
|
2003-07-01 |
2005-04-26 |
International Flavors & Fragrances Inc. |
Menthyl half acid ester derivatives, processes for preparing same, and uses thereof for their cooling/refreshing effect in consumable materials
|
US7141686B2
(en)
*
|
2003-07-10 |
2006-11-28 |
International Flavors & Fragrances Inc. |
E2, E4, Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
KR20060052931A
(ko)
|
2003-07-28 |
2006-05-19 |
알자 코포레이션 |
경피용 와파린-포함 전달 시스템
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
EP1660056A4
(de)
*
|
2003-08-15 |
2008-12-17 |
Arius Two Inc |
Adhäsives bioerodierbares transmukosales arzneimittelabgabesystem
|
US20050043283A1
(en)
*
|
2003-08-22 |
2005-02-24 |
L'oreal S.A. |
Compositions containing topical active agents and pentylene glycol
|
US20060018852A1
(en)
|
2003-08-22 |
2006-01-26 |
L'oreal |
Compositions containing topical active agents and pentylene glycol
|
US20060263350A1
(en)
*
|
2003-09-26 |
2006-11-23 |
Fairfield Clinical Trials Llc |
Combination antihistamine medication
|
US8007839B2
(en)
*
|
2003-10-03 |
2011-08-30 |
International Flavors & Fragrances |
Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
|
US7329767B2
(en)
*
|
2003-10-03 |
2008-02-12 |
International Flavors & Fragrances Inc. |
Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
|
US7387788B1
(en)
|
2003-10-10 |
2008-06-17 |
Antares Pharma Ipl Ag |
Pharmaceutical compositions of nicotine and methods of use thereof
|
AU2004283431B2
(en)
*
|
2003-10-10 |
2009-09-10 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
KR100552650B1
(ko)
*
|
2003-11-17 |
2006-02-20 |
아이큐어 주식회사 |
피록시캄 함유 소염진통용 플라스터
|
EP1541136A1
(de)
*
|
2003-12-10 |
2005-06-15 |
Schering AG |
UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten
|
US20050129756A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Hans-Peter Podhaisky |
UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient
|
CN1889994A
(zh)
*
|
2003-12-10 |
2007-01-03 |
艾克若克斯Dds有限公司 |
伴随透皮或局部药物输送的不希望的效果的治疗方法
|
EP1547592A1
(de)
|
2003-12-23 |
2005-06-29 |
Schwarz Pharma Ag |
Intranasale formulierung enthaltend
|
DE10361258A1
(de)
|
2003-12-24 |
2005-07-28 |
Schwarz Pharma Ag |
Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
|
DE102004014841B4
(de)
|
2004-03-24 |
2006-07-06 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US8907153B2
(en)
|
2004-06-07 |
2014-12-09 |
Nuvo Research Inc. |
Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
|
US8741333B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for treating dermatitis or psoriasis
|
US8741332B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for dermally treating neuropathic pain
|
CA2569964A1
(en)
*
|
2004-06-10 |
2005-12-29 |
Duramed Pharmaceuticals, Inc. |
Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
|
US20060030574A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Shire Holdings Ag |
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
|
US7700608B2
(en)
*
|
2004-08-04 |
2010-04-20 |
Shire Holdings Ag |
Quinazoline derivatives and their use in the treatment of thrombocythemia
|
WO2006028863A1
(en)
*
|
2004-09-01 |
2006-03-16 |
Nexmed Holdings, Inc. |
Transdermal antiemesis delivery system, method and composition therefor
|
US7541055B2
(en)
*
|
2004-09-10 |
2009-06-02 |
International Flavors & Fragrances Inc. |
Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
|
US7427421B2
(en)
*
|
2004-09-10 |
2008-09-23 |
International Flavors & Fragrances Inc. |
Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
|
SI1814531T1
(sl)
|
2004-10-21 |
2010-10-29 |
Durect Corp |
Transdermalni dostavni sistem
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
US7001592B1
(en)
|
2005-01-31 |
2006-02-21 |
Aquea Scientific Corporation |
Sunscreen compositions and methods of use
|
WO2006084312A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Acrux Dds Pty Ltd |
Method of promoting hair growth
|
CN101189000A
(zh)
*
|
2005-02-14 |
2008-05-28 |
纽罗吉斯克斯公司 |
Trpv1激动剂的递送装置
|
CA2597956C
(en)
|
2005-02-17 |
2013-07-09 |
Velcera Pharmaceuticals |
Transmucosal administration of drug compositions for treating and preventing disorders in animals
|
US20080112904A1
(en)
*
|
2005-03-08 |
2008-05-15 |
Daniel Henry Traynor |
Sunscreen Compositions And Methods Of Use
|
EP1865978A4
(de)
|
2005-03-21 |
2012-01-25 |
Univ Columbia |
Neue neuronale schmerzbahn
|
US20090061001A1
(en)
*
|
2005-03-24 |
2009-03-05 |
Ensign Laboratories Pty Ltd |
Sunscreen aerosol spray
|
AU2006227561B2
(en)
*
|
2005-03-24 |
2011-06-09 |
Ensign Laboratories Pty Ltd |
Sunscreen aerosol spray
|
WO2006105481A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Neurogesx, Inc. |
Low-concentration capsaicin patch and methods for treating neuropathic pain
|
US20060222692A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Fairfield Clinical Trials Llc |
Method and compositions for transdermal administration of antimicrobial medications
|
WO2007124250A2
(en)
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
EP1887864B1
(de)
*
|
2005-05-16 |
2020-02-12 |
Novapharm Research (Australia) Pty. Limited |
Zusammensetzung für die vorbereitung eines patienten für chirurgische eingriffe
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
ES2607454T3
(es)
|
2005-06-03 |
2017-03-31 |
Acrux Dds Pty Ltd |
Método y composición para el suministro transdérmico de testosterona
|
CA2610708C
(en)
|
2005-06-03 |
2013-10-08 |
Acrux Dds Pty Ltd |
Method and composition for transdermal drug delivery
|
JP4696701B2
(ja)
|
2005-06-07 |
2011-06-08 |
ソニー株式会社 |
抵抗回路
|
JP5095615B2
(ja)
*
|
2005-06-27 |
2012-12-12 |
バリアント・インターナショナル・(バルバドス)・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ |
ブプロピオン塩の放出調整製剤
|
KR100699582B1
(ko)
|
2005-07-11 |
2007-03-23 |
삼성전기주식회사 |
출력 버퍼회로
|
JP5465431B2
(ja)
*
|
2005-07-27 |
2014-04-09 |
アルケミア オンコロジー ピーティーワイ リミテッド |
ヒアルロナンを用いる治療プロトコル
|
AU2005334836B2
(en)
*
|
2005-07-28 |
2012-04-12 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Sensitization of immune system against haptenized melanoma antigens
|
US8623354B2
(en)
*
|
2005-09-07 |
2014-01-07 |
Alchemia Oncology Pty Limited |
Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
|
TR201815853T4
(tr)
|
2005-10-12 |
2018-11-21 |
Besins Healthcare Sarl |
Hipogonadizmin tedavisinde kullanıma yönelik geliştirilmiş testosteron jeli.
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
WO2007051243A1
(en)
*
|
2005-11-04 |
2007-05-10 |
Acrux Dds Pty Ltd |
Method and system for transdermal drug delivery
|
RU2008124805A
(ru)
*
|
2005-11-21 |
2009-12-27 |
Шеринг-Плоу Лтд. (CH) |
Фармацевтические композиции, содержащие бупренорфин
|
GB0524961D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Transdermal administration of active agents for systemic effect
|
GB0524958D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Transdermal administration of active agents
|
EP1962795A1
(de)
*
|
2005-12-07 |
2008-09-03 |
PharmaKodex Ltd |
Topische zusammensetzungen zur anwendung bei kindern
|
GB0524962D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Pharmakodex Ltd |
Topical pharmaceutical compositions
|
AU2006326388B2
(en)
*
|
2005-12-14 |
2013-01-24 |
Nuvo Research Inc. |
Compositions and methods for treating dermatological conditions
|
WO2007070679A2
(en)
*
|
2005-12-14 |
2007-06-21 |
Zars, Inc. |
Compositions and methods for dermally treating pain
|
US9017717B2
(en)
*
|
2006-01-16 |
2015-04-28 |
Peach Technologies Llc |
Bandage for facilitating transdermal respiration and healing
|
CN101466407B
(zh)
*
|
2006-01-24 |
2013-05-15 |
株式会社·R-技术上野 |
包含双环化合物的药物组合物和使所述双环化合物稳定的方法
|
US8846742B2
(en)
|
2006-02-14 |
2014-09-30 |
The Trustees Of Columbia University In The City Of New York |
Neuronal pain pathway modulators
|
DE102006010329A1
(de)
*
|
2006-03-06 |
2007-09-13 |
Höltge, Michael, Dipl.-Med. |
Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
|
US20080044462A1
(en)
*
|
2006-04-06 |
2008-02-21 |
Collegium Pharmaceutical, Inc. Delaware |
Stabilized transdermal bupropion preparations
|
EP2015632B1
(de)
*
|
2006-04-19 |
2015-12-02 |
Mist Pharmaceuticals, LLC |
Stabile wässrig-alkoholische mundsprayformulierungen und verfahren
|
US9468600B2
(en)
|
2006-05-26 |
2016-10-18 |
Dr. Holmquist Healthcare, LLC |
Compositions for the transdermal delivery of physiologically active agents
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
US20080090850A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Anderson Mark E |
Herpetic neuralgia topical treatment
|
DE102006050558B4
(de)
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
US7910597B2
(en)
*
|
2006-11-28 |
2011-03-22 |
Shire Llc |
Substituted quinazolines
|
US8304420B2
(en)
|
2006-11-28 |
2012-11-06 |
Shire Llc |
Substituted quinazolines for reducing platelet count
|
CA2673049C
(en)
*
|
2006-12-22 |
2016-02-23 |
Novadel Pharma Inc. |
Stable anti-nausea oral spray formulations and methods
|
AU2008205312B2
(en)
*
|
2007-01-08 |
2013-11-21 |
Annji Pharmaceutical Co., Ltd. |
Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
|
EP2106272A4
(de)
|
2007-01-11 |
2011-05-04 |
Acrux Dds Pty Ltd |
Spreizutensil
|
JP5319121B2
(ja)
|
2007-01-30 |
2013-10-16 |
株式会社東芝 |
診療支援システム及び診療支援装置
|
EP2121088B1
(de)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung
|
EP2124907B1
(de)
|
2007-03-19 |
2018-05-30 |
Vita Sciences, Llc |
Transdermales pflaster und verfahren zur verabreichung von vitamin b12
|
WO2008128280A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Acrux Dds Pty Ltd |
Method and system for transdermal administration of volatile active
|
CN101801346A
(zh)
*
|
2007-05-10 |
2010-08-11 |
诺瓦德尔药品公司 |
抗失眠症组合物及方法
|
WO2008144734A1
(en)
*
|
2007-05-21 |
2008-11-27 |
Aquea Scientific Corporation |
Highly charged microcapsules
|
DE102007032468A1
(de)
|
2007-07-10 |
2009-01-15 |
Brätter, Christian, Dr. |
Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
|
HU227970B1
(en)
*
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
AR068408A1
(es)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Pulverizacion de hormonas transdermicas
|
AR068409A1
(es)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Composiciones farmaceuticas, transdermicas sin alcohol
|
PL2214643T3
(pl)
*
|
2007-11-02 |
2014-09-30 |
Acrux Dds Pty Ltd |
Układ transdermalnego dostarczania hormonów i steroidów
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
EP2242476A2
(de)
|
2008-01-14 |
2010-10-27 |
Foamix Ltd. |
Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
|
WO2009092040A2
(en)
*
|
2008-01-17 |
2009-07-23 |
Gary Dean Bennett |
Topical pain formulation
|
US8123082B2
(en)
*
|
2008-01-22 |
2012-02-28 |
McNeil-AB |
Hand-held dispensing device
|
KR20110007088A
(ko)
*
|
2008-01-25 |
2011-01-21 |
비 앤드 티 에스.알.엘. |
화장품 분야에서의 트랜스에스테르화 올리브 오일의 용도
|
JP4879928B2
(ja)
*
|
2008-03-25 |
2012-02-22 |
帝國製薬株式会社 |
ケトプロフェンリジン塩を含有する水性貼付剤
|
US20090259176A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Los Gatos Research, Inc. |
Transdermal patch system
|
US20110097393A1
(en)
*
|
2008-06-25 |
2011-04-28 |
US WorldMeade, LLC |
Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery
|
US20100048598A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Sateesh Kandavilli |
Topical compositions comprising 5-alpha reductase inhibitors
|
US8650937B2
(en)
|
2008-09-19 |
2014-02-18 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
US8748177B2
(en)
*
|
2008-09-30 |
2014-06-10 |
The Hospital For Sick Children |
Compositions for proliferation of cells and related methods
|
RU2497679C2
(ru)
|
2008-10-02 |
2013-11-10 |
Милан Инк. |
Способ получения многослойного клеящегося ламинированного материала
|
US9226918B2
(en)
*
|
2008-12-04 |
2016-01-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for treating or preventing narcotic withdrawal symptoms
|
CA2753214C
(en)
|
2009-02-27 |
2017-07-25 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US9250106B2
(en)
|
2009-02-27 |
2016-02-02 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
US20100298397A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Singh Nikhilesh N |
Method of treatment of obsessive compulsive disorder with ondansetron
|
US9517023B2
(en)
|
2009-06-01 |
2016-12-13 |
Profusa, Inc. |
Method and system for directing a localized biological response to an implant
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
EP2724739B1
(de)
|
2009-07-30 |
2015-07-01 |
Tandem Diabetes Care, Inc. |
Tragbares Infusionspumpensystem
|
MX359879B
(es)
|
2009-10-02 |
2018-10-12 |
Foamix Pharmaceuticals Ltd |
Composiciones tópicas de tetraciclina.
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
WO2011044540A1
(en)
|
2009-10-09 |
2011-04-14 |
Nuvo Research Inc. |
Topical formulation comprising etoricoxib and a zwitterionic surfactant
|
US9078863B2
(en)
*
|
2009-11-13 |
2015-07-14 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
US8439896B2
(en)
*
|
2009-11-13 |
2013-05-14 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
US8894630B2
(en)
*
|
2009-11-13 |
2014-11-25 |
The Invention Science Fund I, Llc |
Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
|
AU2011239636A1
(en)
|
2010-04-13 |
2012-11-22 |
Najib Babul |
Dermal pharmaceutical compositions of 1-Methyl-2',6'-pipecoloxylidide and method of use
|
KR20130079382A
(ko)
*
|
2010-05-04 |
2013-07-10 |
넥스메드 홀딩스 인코포레이티드 |
소분자 치료제의 조성물
|
US10010272B2
(en)
|
2010-05-27 |
2018-07-03 |
Profusa, Inc. |
Tissue-integrating electronic apparatus
|
US20120022033A1
(en)
*
|
2010-07-23 |
2012-01-26 |
Biosante Pharmaceuticals, Inc. |
Methods for decreasing cardiovascular risk in postmenopausal women
|
WO2012037193A2
(en)
|
2010-09-17 |
2012-03-22 |
Brassica Protection Products Llc |
Formulations for treatment with glucosinolate
|
KR101690535B1
(ko)
|
2010-10-06 |
2017-01-09 |
프로퓨사 인코퍼레이티드 |
조직-일체화 센서
|
EP2606895A4
(de)
*
|
2010-10-12 |
2014-04-02 |
Univ Wuhan |
Pflaster zur transdermalen absorption eines antivirus-wirkstoffs und verfahren zu seiner herstellung
|
SE535588C2
(sv)
*
|
2010-10-29 |
2012-10-02 |
Redsense Medical Ab |
Detektion av blodläckage genom påvisning av förekomsten av flyktiga ämnen
|
US9642862B2
(en)
|
2010-11-18 |
2017-05-09 |
White Mountain Pharma, Inc. |
Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
|
ES2784627T3
(es)
|
2011-02-15 |
2020-09-29 |
Audevard |
Métodos para controlar el dolor en equinos utilizando una disolución transdérmica de fentanilo
|
EP2675453B1
(de)
|
2011-02-15 |
2018-08-08 |
Elanco US Inc. |
Verfahren zur steuerung von schmerzen bei hunden unter verwendung einer transdermalen fentanyllösung
|
US9119793B1
(en)
|
2011-06-28 |
2015-09-01 |
Medicis Pharmaceutical Corporation |
Gastroretentive dosage forms for doxycycline
|
US8394359B1
(en)
*
|
2011-08-26 |
2013-03-12 |
Michael P. O'Neil |
Tattoo removal system and method
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
HUE055562T2
(hu)
|
2011-11-23 |
2021-11-29 |
Therapeuticsmd Inc |
Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
|
CN103181956B
(zh)
*
|
2011-12-30 |
2015-04-29 |
天津市山佳医药科技有限公司 |
一种治疗退行性骨关节痛的透皮吸收贴剂
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10045965B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
US11154535B2
(en)
|
2012-07-31 |
2021-10-26 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
US10045935B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
DK2897620T3
(da)
|
2012-09-21 |
2020-08-17 |
Intensity Therapeutics Inc |
Fremgangsmåde til behandling af cancer
|
US9694050B2
(en)
|
2012-10-21 |
2017-07-04 |
University Of Rochester |
THY1 (CD90) as a novel therapy to control adipose tissue accumulation
|
US11724134B2
(en)
|
2012-11-06 |
2023-08-15 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11707421B2
(en)
|
2012-11-06 |
2023-07-25 |
Colabs Int'l Corp. |
Compositions containing a flexible derived capsule with an active agent
|
US11491088B2
(en)
|
2012-11-06 |
2022-11-08 |
CoLabs International Corporation |
Compositions containing a capsule with a moisturizing agent
|
JP2015536985A
(ja)
|
2012-11-06 |
2015-12-24 |
コラブス インターナショナル コーポレーション |
日焼け止めを含むセルロース由来カプセル含有組成物
|
US10322301B2
(en)
|
2012-11-06 |
2019-06-18 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11690793B2
(en)
|
2012-11-06 |
2023-07-04 |
Colabs Int'l Corp. |
Composition containing a cellulose derived capsule with a sunscreen
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
WO2014122627A1
(en)
|
2013-02-11 |
2014-08-14 |
Glycanova As |
Basidiomycete-derived cream for treatment of skin diseases
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
JP6457998B2
(ja)
|
2013-03-14 |
2019-01-23 |
プロフサ,インコーポレイテッド |
光信号を補正するための方法およびデバイス
|
US10842802B2
(en)
|
2013-03-15 |
2020-11-24 |
Medicis Pharmaceutical Corporation |
Controlled release pharmaceutical dosage forms
|
JP2016523608A
(ja)
|
2013-06-06 |
2016-08-12 |
プロフサ,インコーポレイテッド |
埋込センサからの光信号を検出する装置及び方法
|
USD750788S1
(en)
|
2013-11-26 |
2016-03-01 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
USD749225S1
(en)
|
2013-11-26 |
2016-02-09 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
US9227044B2
(en)
|
2013-12-09 |
2016-01-05 |
Amneal Pharmaceuticals Llc |
Applicator for applying a fluid to a surface
|
USD752287S1
(en)
|
2013-12-09 |
2016-03-22 |
Amneal Pharmaceuticals Llc |
Applicator for applying a liquid to a surface
|
JP6523291B2
(ja)
*
|
2013-12-24 |
2019-05-29 |
ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company |
スキンケア有効成分の高い浸透性を与える美容組成物及び方法
|
US9561233B2
(en)
|
2014-03-13 |
2017-02-07 |
Demerx, Inc. |
Use of ibogaine for the treatment of pain
|
KR102364378B1
(ko)
|
2014-05-21 |
2022-02-16 |
에스케이케미칼 주식회사 |
안정성을 향상시킨 로티고틴 함유 경피흡수제제
|
EP3145489A1
(de)
|
2014-05-22 |
2017-03-29 |
TherapeuticsMD, Inc. |
Natürliche kombinierte hormonersatzformulierungen und therapien
|
US10470992B2
(en)
|
2014-05-23 |
2019-11-12 |
Triple Hair Inc. |
Compositions for reducing hair loss and/or increasing hair regrowth
|
US11696883B2
(en)
|
2014-05-23 |
2023-07-11 |
Triple Hair Inc. |
Compositions for reducing hair loss and/or increasing hair regrowth
|
US20160022643A1
(en)
*
|
2014-07-22 |
2016-01-28 |
Professional Compounding Centers Of America |
Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
|
US9592239B2
(en)
|
2014-09-12 |
2017-03-14 |
Demerx, Inc. |
Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
ES2846882T3
(es)
|
2015-03-23 |
2021-07-30 |
Biopharmx Inc |
Composición farmacéutica de tetraciclina para uso dermatológico
|
US20160307158A1
(en)
*
|
2015-04-16 |
2016-10-20 |
Linkedin Corporation |
Aggregating and transforming user actions into social signal features for a job recommendation engine
|
PL3347009T3
(pl)
|
2015-07-08 |
2022-02-07 |
Triple Hair Inc. |
Kompozycja zawierająca resweratrol i melatoninę ograniczająca wypadanie włosów i/lub zwiększająca odrastanie włosów
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
BR112018070199A2
(pt)
|
2016-04-01 |
2019-01-29 |
Therapeuticsmd Inc |
composição farmacêutica de hormônio esteroide
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
US10549129B2
(en)
|
2016-06-24 |
2020-02-04 |
The Procter & Gamble Company |
Cosmetic compositions and methods providing enhanced penetration of skin care actives
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
KR102499141B1
(ko)
|
2016-10-31 |
2023-02-13 |
신신제약 주식회사 |
수면장애 치료용 경피흡수제제
|
WO2018118197A1
(en)
*
|
2016-12-21 |
2018-06-28 |
Richard Postrel |
Healthier aging in domesticated animals
|
WO2018119400A1
(en)
|
2016-12-22 |
2018-06-28 |
Profusa, Inc. |
System and single-channel luminescent sensor for and method of determining analyte value
|
WO2018129304A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
US10396053B2
(en)
*
|
2017-11-17 |
2019-08-27 |
General Electric Company |
Semiconductor logic device and system and method of embedded packaging of same
|
US11523994B2
(en)
|
2018-01-10 |
2022-12-13 |
Celista Pharmaceuticals Llc |
Testosterone transdermal spray with film
|
EP3801732A4
(de)
|
2018-05-29 |
2022-04-27 |
Morningside Venture Investments Limited |
Verfahren und systeme zur wirkstofffreisetzung
|
EP3813786A4
(de)
|
2018-06-27 |
2022-06-29 |
Colabs International Corporation |
Zusammensetzungen mit siliziumdioxidbasierten partikeln, die ein oder mehrere mittel enthalten
|
WO2020102695A1
(en)
*
|
2018-11-16 |
2020-05-22 |
Cti (Assignment For Benefit Of Creditors) Llc |
Thermally regulated transdermal drug delivery system
|
US20220249465A1
(en)
*
|
2019-05-31 |
2022-08-11 |
Primo Pharmatech Llc |
Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
KR102503159B1
(ko)
|
2020-04-29 |
2023-02-23 |
신신제약 주식회사 |
멜라토닌을 함유하는 경피흡수제제
|